查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576099

美國的動物用診斷藥市場:各產品，各技術，各動物類型，各用途，各終端用戶，各地區，機會，預測，2017年～2031年

United States Veterinary Diagnostics Market Assessment, By Product, By Technology, By Animal Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 133 Pages | 商品交期: 3-5個工作天內

價格

2024-2031年預測期間，美國獸醫診斷市場規模將以8.02%的複合年增長率擴大，從2023年的20.4803億美元增長到2031年的37.9684億美元。市場的成長受到資金增加、新產品開發增加、技術進步、傳染病威脅日益增加以及對主要市場參與者之間合作和聯盟的支持的支持。透過確保牲畜的健康和福利以及及早發現患病動物來保護食品供應鏈的市場需求不斷增加。

全國各地的各種研究和教育機構正在努力透過支持基礎設施擴建來提高其研究能力，以支持先進獸醫診斷解決方案的發展。例如，愛荷華州立大學於 2024 年 4 月開始了新獸醫診斷實驗室 (VDL) 建設計畫的第二階段。透過這個新設施，VDL 旨在加強其在確保和促進動物健康、公共衛生和食品安全方面作為國家領導者的地位。該設施擁有全國最重要的動物裝箱量之一，為世界各地領先的家禽和牲畜生產商提供服務。該設施的擴建預計將促進創新、推動獸醫診斷醫學並提高該國新技術的可用性。

此外，進入市場的公司不斷努力開發和引進新技術也支持了市場成長。 2024 年 9 月，碩騰服務有限責任公司推出了 Vetscan OptiCall，這是一種由人工智慧驅動的診斷工具，用於進階全血細胞計數 (CBC) 分析。此血液分析儀可提供高品質的結果，佔地面積緊湊，並可提高效率。

本報告提供美國的動物用診斷藥市場相關調查，提供市場概要，以及各產品，各技術，各動物類型，各用途，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 美國的動物用診斷藥市場預測，2017年～2031年

  • 市場規模的分析與預測
  • 市場佔有率分析與預測
  • 市場地圖分析，2023年
    • 各產品
    • 各技術
    • 各動物類型
    • 各用途
    • 各終端用戶
    • 各地區

第5章 需求供給分析

第6章 進出口的分析

第7章 價值鏈分析

第8章 波特的五力分析

第9章 大環境分析

第10章 價格分析

第11章 市場動態

第12章 市場趨勢與發展

第13章 法規結構和革新

第14章 專利的形勢

第15章 案例研究

第16章 競爭情形

  • 前5名市場領導者的競爭矩陣
  • 前5名參與企業的SWOT分析
  • 前10名市場主要參與企業的形勢
    • IDEXX Laboratories, Inc.
    • Zoetis Services LLC
    • Thermo Fisher Scientific, Inc.
    • Neogen Corporation
    • Heska Corporation (Mars Petcare)
    • Bio-Rad Laboratories, Inc.
    • PepiPets, Inc.
    • Virbac S.A.
    • FUJIFILM Holdings Corporation
    • bioMerieux SA

第17章 策略性建議

第18章 諮詢方式和免責聲明

Product Code: MX12146

United States veterinary diagnostics market is projected to witness a CAGR of 8.02% during the forecast period 2024-2031, growing from USD 2,048.03 million in 2023 to USD 3,796.84 million in 2031. The growth of the market is supported by increasing funding, rising development of novel products, technological advancements, the growing threat of infectious diseases, and supportive collaborations and partnerships by key market players. The market's demand is increasing to protect the food supply chain by ensuring the health and well-being of the livestock and early detection of diseased animals.

Various research and educational institutions across the country are working towards improving their research capabilities by supporting infrastructural expansion, to support the development of advanced veterinary diagnostic solutions. For instance, in April 2024, Iowa State University started the second phase of its new Veterinary Diagnostic Laboratory's (VDL) construction project. With the new facility, the VDL aims to strengthen its position as the national leader in ensuring and advancing animal health, public health, and food safety. The facility has the most significant animal caseload in the country and serves some of the most advanced poultry and livestock producers across the globe. The expansion of the facility is expected to foster innovation and advance veterinary diagnostic medicine, bolstering the availability of novel technologies in the country.

Furthermore, the increasing efforts of the market players towards the development and introduction of novel technologies are supporting the growth of the market. In September 2024, Zoetis Services LLC launched Vetscan OptiCall, a diagnostic tool powered by artificial intelligence to receive an advanced Complete Blood Count (CBC) analysis. The hematology analyzer delivers high-quality results, provides a compact footprint, and enables improved efficiency.

Increasing Fundings to Support Market Expansion

The increasing funding initiatives to advance research activities and facilitate innovations related to veterinary diagnostics is boosting the growth of the United States veterinary diagnostics market. The rising funding is expected to improve the understanding of animal health and various infectious diseases, which in turn will allow researchers to develop innovative diagnostic solutions to combat the rising threat of different diseases among animals. Additionally, various veterinary diagnostic laboratories across the country are receiving funding for enhancement and expansion of their infrastructure. In July 2024, the New York State Veterinary Diagnostic Laboratory (NYSVDI) received USD 19.5 million in capital funding to expand its building to meet the increasing caseload. The construction project will add 26,000 square feet to the workstation, offices, conferences, training labs, laboratories, and space for storage and material preparation. Additionally, the expansion is expected to provide workforce development opportunities for training qualified diagnosticians.

Technological Advancements to Boost Market Growth

The development and integration of novel technologies with veterinary diagnostic solutions is propelling the market's expansion. The advancements in veterinary diagnostics over the past few years have allowed the improvement of outcomes, increased convenience, and ensure the delivery of enhanced patient care. Advancements in imaging technologies, including magnetic resonance imaging (MRI) and computed tomography (CT) have significantly improved the capabilities of veterinary diagnostics. These technologies ensure the provision of images with high resolutions, allowing for detailed assessment of the organ by veterinarians, allowing them to diagnose complex conditions with ease. Scientists believe that automation will be the next big leap toward the improvement of diagnostic efficiency, and more of the industry's research activities related to diagnostic testing will be conducted with next-generation sequencing technologies and metagenomics. Meanwhile, the introduction of new technologies that aid in delivering information and images at a rapid rate to specialists and practitioners is expected to improve accessibility to patient care and ensure the provision of high-quality services for animals.

The Segment of Companion Animals to Hold Major Market Share

The rising popularity of pet ownership in the country and increasing investments by pet owners toward their health are some of the major factors supporting the segment's expansion. According to the estimates of the American Pet Products Association, in 2023, USD 147 billion was spent on pets in the United States, out of which USD 32 billion was spent on supplies, live animals, and OTC medicine and USD 38.3 billion on vet care, product sales, and others. The increasing proactiveness of pet owners towards the well-being of their pets has resulted in routine health checkups, tests, and vaccinations becoming standard practices. Thus, bolstering the demand for diagnostic tests to identify potential health issues and assess the well-being of the companion animals. Additionally, the growing awareness among the general population about zoonotic diseases is supporting the growth of the segment.

Infectious Diseases to Account for Significant Market Share

The rising cases of infectious diseases and the increasing threat of zoonotic diseases are propelling the market's expansion. Due to the growing awareness about animal health and the threat of such diseases, regular health screenings are being deployed to ensure the early identification of infections to improve treatment outcomes. Additionally, the government is taking various measures to combat different viruses. For instance, in May 2024, the country's federal authorities pledged approximately USD 200 million in efforts to control the rising cases of bird flu on dairy farms. Additionally, the funds are intended to encourage testing of the people who work on the farm on a regular basis and dairy cows to evaluate the scope of bird flu and introduce various measures to combat this growing threat. Such efforts are expected to bolster the requirement for different diagnostic technologies, boosting the demand for the veterinary diagnostics market in the United States.

Future Market Scenario (2024 - 2031F)

The market is expected to witness significant growth opportunities in the forecast years owing to increasing pet ownership, advancements in veterinary diagnostic technologies, and increasing investments in research and development activities.

The growing emphasis on preventive health measures, along with the increasing efforts of veterinarians to promote wellness programs and regular screenings, is expected to bolster the market's demand in the forecast years. Pet and livestock owners are seeking to provide the best care available to ensure the well-being of animals, encouraging the development of targeted diagnostic solutions.

Meanwhile, the growing acceptance of new technologies and increasing diagnostic advancements are further expected to bolster the market's expansion over the forecast period. Innovations, including molecular diagnostics and point-of-care testing, are improving the accuracy and speed of the diagnoses and allowing the delivery of swift results.

Key Players Landscape and Outlook

Investments by market players towards collaborations and partnerships are supporting the development and availability of novel products and technologies, bolstering the growth of the United States veterinary diagnostics market. In January 2022, IDEXX Laboratories, Inc. and PetDx Inc. announced a collaboration to improve canine cancer liquid biopsy testing access. With the help of IDEXX's large distribution network, PetDx aims to augment the availability of OncoK9, their non-invasive cancer testing solution, and accelerate their efforts to introduce novel technologies in the market.

Additionally, in November 2023, Thermo Fisher Scientific Inc. and Flagship Pioneering, Inc. announced the formation of a partnership for commercially scaling and developing multiproduct platforms in an accelerated manner. The partnership aims to extend Flagship's ecosystem and leverage the expertise of the two companies in the areas of diagnostics and life science tools, among others. Flagship's extensive commercial capabilities and Thermo Fisher's technical expertise are expected to bolster the introduction of innovative solutions in the market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. United States Veterinary Diagnostics Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Consumables
      • 4.2.1.2. Instruments
    • 4.2.2. By Technology
      • 4.2.2.1. Immunodiagnostics
        • 4.2.2.1.1. ELISA
        • 4.2.2.1.2. Radioimmunoassays
        • 4.2.2.1.3. Lateral flow Assays
        • 4.2.2.1.4. Others
      • 4.2.2.2. Molecular Diagnostics
        • 4.2.2.2.1. PCR Tests
        • 4.2.2.2.2. Microarrays
        • 4.2.2.2.3. Nucleic Acid Sequencing
      • 4.2.2.3. Clinical Biochemistry
        • 4.2.2.3.1. Clinical Chemistry Analysis
        • 4.2.2.3.2. Glucose Monitoring
        • 4.2.2.3.3. Blood Gas and Electrolyte Analysis
      • 4.2.2.4. Hematology
      • 4.2.2.5. Others
    • 4.2.3. By Animal Type
      • 4.2.3.1. Companion Animals
        • 4.2.3.1.1. Dogs
        • 4.2.3.1.2. Cats
        • 4.2.3.1.3. Horses
        • 4.2.3.1.4. Others
      • 4.2.3.2. Livestock
        • 4.2.3.2.1. Cattle
        • 4.2.3.2.2. Pigs
        • 4.2.3.2.3. Poultry
        • 4.2.3.2.4. Others
    • 4.2.4. By Application
      • 4.2.4.1. Infectious Diseases
        • 4.2.4.1.1. Bacterial Infections
        • 4.2.4.1.2. Parasitic Infections
        • 4.2.4.1.3. Viral Infections
      • 4.2.4.2. Endocrinology
      • 4.2.4.3. Oncology
      • 4.2.4.4. Cardiology
      • 4.2.4.5. Others
    • 4.2.5. By End-user
      • 4.2.5.1. Veterinary Hospitals and Clinics
      • 4.2.5.2. Veterinary Reference Laboratories
    • 4.2.6. By Region
      • 4.2.6.1. Northeast
      • 4.2.6.2. Midwest
      • 4.2.6.3. West
      • 4.2.6.4. South
    • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Technology
    • 4.3.3. By Animal Type
    • 4.3.4. By Application
    • 4.3.5. By End-user
    • 4.3.6. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

  • 11.1. Market Drivers
  • 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

  • 13.1. Clinical Trials
  • 13.2. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

  • 16.1. Competition Matrix of Top 5 Market Leaders
  • 16.2. SWOT Analysis for Top 5 Players
  • 16.3. Key Players Landscape for Top 10 Market Players
    • 16.3.1. IDEXX Laboratories, Inc.
      • 16.3.1.1. Company Details
      • 16.3.1.2. Key Management Personnel
      • 16.3.1.3. Products and Services
      • 16.3.1.4. Financials (As Reported)
      • 16.3.1.5. Key Market Focus and Geographical Presence
      • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 16.3.2. Zoetis Services LLC
    • 16.3.3. Thermo Fisher Scientific, Inc.
    • 16.3.4. Neogen Corporation
    • 16.3.5. Heska Corporation (Mars Petcare)
    • 16.3.6. Bio-Rad Laboratories, Inc.
    • 16.3.7. PepiPets, Inc.
    • 16.3.8. Virbac S.A.
    • 16.3.9. FUJIFILM Holdings Corporation
    • 16.3.10. bioMerieux SA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. United States Veterinary Diagnostics Market, By Value, In USD Million, 2017-2031F
  • Figure 2. United States Veterinary Diagnostics Market Share (%), By Product, 2017-2031F
  • Figure 3. United States Veterinary Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 4. United States Veterinary Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 5. United States Veterinary Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 6. United States Veterinary Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 7. United States Veterinary Diagnostics Market Share (%), By Region, 2017-2031Fs
  • Figure 8. By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 9. By Technology Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 10. By Animal Type Size Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 11. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 12. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 13. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023